Inventor · disambiguated record
Lawrence M. Blatt
Also filed as: BLATT LAWRENCE · BLATT LAWRENCE M
29 granted patents·70 pending applications·854 citations·filing 1988–2025
97Inventor score
Top patents by PatentIndex Score
99 records- 0198US9603864B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2015·Granted Mar 28, 2017·56 cites·48 claims
- 0298US9603863B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2015·Granted Mar 28, 2017·42 cites·25 claims
- 0398US7491794B2Macrocyclic compounds as inhibitors of viral replicationINTERMUNE INC·Filed 2005·Granted Feb 17, 2009·147 cites·1 claims
- 0497US10307439B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2017·Granted Jun 4, 2019·21 cites·63 claims
- 0596US7728013B2Method of modulating stress-activated protein kinase systemINTERMUNE INC·Filed 2006·Granted Jun 1, 2010·40 cites·19 claims
- 0695US9012427B2Pharmaceutical combinations comprising a thionucleotide analogALIOS BIOPHARMA INC·Filed 2013·Granted Apr 21, 2015·46 cites·41 claims
- 0795US8119592B2Compounds and methods for inhibiting hepatitis C viral replicationBEIGELMAN LEONID·Filed 2006·Granted Feb 21, 2012·54 cites·13 claims
- 0894US10052342B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2017·Granted Aug 21, 2018·16 cites·22 claims
- 0994US8299021B2Macrocyclic inhibitors of hepatitis C virus replicationBLATT LAWRENCE M·Filed 2012·Granted Oct 30, 2012·47 cites·2 claims
- 1094US5372808AMethods and compositions for the treatment of diseases with consensus interferon while reducing side effectAMGEN INC·Filed 1992·Granted Dec 13, 1994·216 cites·16 claims
- 1193US10780105B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2018·Granted Sep 22, 2020·4 cites·37 claims
- 1293US7829665B2Macrocyclic inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2006·Granted Nov 9, 2010·27 cites·29 claims
- 1389US8741936B2Method of modulating stress-activated protein kinase systemBLATT LAWRENCE M·Filed 2012·Granted Jun 3, 2014·11 cites·5 claims
- 1488US7597884B2Hyperglycosylated polypeptide variants and methods of useALIOS BIOPHARMA INC·Filed 2006·Granted Oct 6, 2009·11 cites·27 claims
- 1588US7407973B2Use of pirfenidone in therapeutic regimensINTERMUNE INC·Filed 2004·Granted Aug 5, 2008·36 cites·18 claims
- 1687US7638488B2Use of alpha-glucosidase inhibitors to treat alphavirus infectionsINTERMUNE INC·Filed 2006·Granted Dec 29, 2009·3 cites·20 claims
- 1785US11166976B2S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2020·Granted Nov 9, 2021·1 cites·6 claims
- 1885US7781474B2Inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2007·Granted Aug 24, 2010·7 cites·13 claims
- 1982US7932267B2Use of α-glucosidase inhibitors to treat alphavirus infectionsINTERMUNE INC·Filed 2009·Granted Apr 26, 2011·1 cites·15 claims
- 2081US9504705B2Hepatitis C viral infection treatment using a combination of compoundsALIOS BIOPHARMA INC·Filed 2014·Granted Nov 29, 2016·6 cites·23 claims
- 2175US7932277B2Peptide inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2008·Granted Apr 26, 2011·2 cites·79 claims
- 2274US9527816B2Method of modulating stress-activated protein kinase systemINTERMUNE INC·Filed 2014·Granted Dec 27, 2016·1 cites·24 claims
- 2373US5831062AUse of the human interferon consensus gene for gene therapyAMGEN INC·Filed 1997·Granted Nov 3, 1998·26 cites·2 claims
- 2471US11590155B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 28, 2023·0 cites·30 claims
- 2568US2009111982A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 2667US2009286843A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 2766US2022125825A1S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2865US2009226400A1Continuous delivery methods for treating hepatitis virus infectionTHREE RIVERS PHARMACEUTICALS L·Filed 2009·Application pending·0 cites
- 2965US2009105471A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 3065US2009111969A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 3163US10010536B2Method of modulating stress-activated protein kinase systemINTERMUNE INC·Filed 2016·Granted Jul 3, 2018·0 cites·4 claims
- 3262US2009169510A1Novel macrocyclic inhibitors of hepatitis c virus replicationINTERMUNE INC·Filed 2008·Application pending·0 cites
- 3360US2011008289A1Hyperglycosylated polypeptide variants and methods of useALIOS BIOPHARMA INC·Filed 2009·Application pending·0 cites
- 3460US2010099851A1Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the sameALIOS BIOPHARMA INC·Filed 2009·Application pending·0 cites
- 3559US5017495APlasmid encoding the Pseudomonas mendocina toluene monooxygenase geneAMGEN INC·Filed 1988·Granted May 21, 1991·15 cites·21 claims
- 3659US2022160748A1Conjugates of s-antigen transport inhibiting oligonucleotide polymers having enhanced liver targetingALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3759US2007026394A1Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologiesBLATT LAWRENCE·Filed 2002·Application pending·0 cites
- 3858US2009148407A1Novel Macrocyclic Inhibitors of Hepatitis C Virus ReplicationINTERMUNE INC·Filed 2006·Application pending·0 cites
- 3957US2025382618A1Methods and compositions for inhibiting virusALIGOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4056US2007258946A1Combination Therapy for Treating Hepatitis C Virus InfectionBLATT LAWRENCE M·Filed 2004·Application pending·0 cites
- 4155US2021189392A1S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4255US2012046321A1Methods of treating atrial fibrillation with p38 inhibitor compoundsOLGIN JEFF·Filed 2011·Application pending·0 cites
- 4354US2007032457A1Combination therapy for cancer treatmentBLATT LAWRENCE M·Filed 2004·Application pending·0 cites
- 4454US2006198823A1Compositions and methods for treating viral infectionsBLATT LAWRENCE M·Filed 2004·Application pending·0 cites
- 4554US2007072181A1Combination therapy for treating alphavirus infection and liver fibrosisBLATT LAWRENCE M·Filed 2004·Application pending·0 cites
- 4653US2009068142A1Compositions and methods for treating coronavirus infection and sarsTHREE RIVERS PHARMACEUTICALS L·Filed 2008·Application pending·0 cites
- 4753US2007154454A1Compositions and methods for treating poxvirus infectionMURPHY BRIAN·Filed 2004·Application pending·0 cites
- 4852US2010240704A1Method of modulating stress-activated protein kinase systemBLATT LAWRENCE M·Filed 2010·Application pending·0 cites
- 4952US2005002901A1Compositions and methods for treating coronavirus infection and SARSFiled 2004·Application pending·0 cites
- 5052US2010029578A1Methods of Treating Atrial Fibrillation with P38 Inhibitor CompoundsOLGIN JEFF·Filed 2006·Application pending·0 cites
Showing the top 50 of 99 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lawrence M. Blatt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →